Personalized care intervention for older adults with diabetes using non-invasive technology
Technological-based Personalized Care Intervention for Supporting Older People With Diabetes Mellitus
This study is testing a new way to help older adults with Type II diabetes manage their condition better using non-invasive technology for glucose monitoring compared to traditional methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Hong Kong Metropolitan University Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06783907 on ClinicalTrials.gov |
What this trial studies
This project aims to develop a new model for managing diabetes mellitus (DM) in older adults by utilizing non-invasive healthcare technology for continuous glucose monitoring. It will employ health apps to provide timely, personalized care interventions to enhance self-management compliance. The study will compare the effectiveness of non-invasive glucose monitoring against traditional invasive methods through a randomized controlled trial with two treatment arms. Participants will be older adults diagnosed with Type II DM who have experienced hypo- or hyperglycemia, and the study will focus on improving self-management skills and reducing hospital admissions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 60 and older diagnosed with Type II diabetes who do not require insulin injections.
Not a fit: Patients on dialysis or those taking certain medications that may affect glucose monitoring results will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve diabetes management and patient outcomes for older adults by providing a more comfortable and effective monitoring method.
How similar studies have performed: Other studies have shown promise in using non-invasive monitoring technologies for diabetes management, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged ≥ 60 years old; 2. patients diagnosed with Type II DM without insulin injections; 3. patients experienced hypo (histix \< 4.0 mmol/L) or hyperglycemia (histix * 16.0 mmol/L); \& 2. The Abbreviated Mental Test (AMT) ≥ 6. Exclusion Criteria: 1. patient on dialysis; 2. taking ascorbic acid \> 500mg daily or (Not recommended by manufacturer as result may be affected); 3. taking salicylic acid ≥ 650mg single dose or (Not recommended by manufacturer as result may be affected); or 4. scheduled radiological therapy during CGM application (Not recommended by manufacturer as result may be affected).
Where this trial is running
Hong Kong
- LEI FOOK Neighbourhood Elderly Centre — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Queenie Law, PhD
- Email: qlaw@hkmu.edu.hk
- Phone: 39702974
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.